Rhenman & Partners Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.48M | Sell |
90,800
-18,800
| -17% | -$1.96M | 1.2% | 35 |
|
|
2025
Q1 | $12.8M | Sell |
109,600
-13,000
| -11% | -$1.52M | 1.47% | 29 |
|
|
2024
Q4 | $10.4M | Hold |
122,600
| – | – | 1.07% | 37 |
|
|
2024
Q3 | $11M | Sell |
122,600
-5,000
| -4% | -$449K | 0.89% | 38 |
|
|
2024
Q2 | $10.3M | Sell |
127,600
-16,000
| -11% | -$1.29M | 0.99% | 37 |
|
|
2024
Q1 | $11.5M | Buy |
143,600
+64,500
| +82% | +$5.15M | 1.09% | 32 |
|
|
2023
Q4 | $6.3M | Buy |
79,100
+39,000
| +97% | +$3.1M | 0.63% | 52 |
|
|
2023
Q3 | $2.8M | Hold |
40,100
| – | – | 0.3% | 67 |
|
|
2023
Q2 | $2.88M | Buy |
40,100
+25,100
| +167% | +$1.8M | 0.3% | 69 |
|
|
2023
Q1 | $908K | Buy |
+15,000
| New | +$908K | 0.1% | 85 |
|